Medi-Caps Limited (MEDICAPQ.BO)
INR 50.9
(0.04%)
INR 50.9
(0.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 69.43 Million | -60.81 Million | 70.21 Million | 153.18 Million | 46.3 Million | 59.62 Million |
| Net Income | -22.4 Million | 49.2 Million | 100.57 Million | 112.39 Million | -58.43 Million | 55.03 Million |
| Depreciation & Amortization | 16.86 Million | 18.11 Million | 19.02 Million | 18.52 Million | 17.09 Million | 18.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 28.55 Million | -102.03 Million | -64.39 Million | -2.86 Million | 75.61 Million | -12.61 Million |
| Other non-cash items | 90.34 Million | -26.09 Million | 15 Million | 25.12 Million | 12.03 Million | -1 Million |
| Investing Cash Flow | -77.35 Million | -25.6 Million | -40.75 Million | -96.99 Million | -58.01 Million | -57.51 Million |
| Investments in PPE | -3.45 Million | -11.62 Million | -27.93 Million | -22.56 Million | -12.54 Million | -5.87 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -73.89 Million | -14 Million | -12.81 Million | -74.42 Million | -45.47 Million | -51.64 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -77.3 Million | 28 Thousand | - | - | 477.00 | 200.00 |
| Financing Cash Flow | - | - | - | -635 Thousand | -580.47 Thousand | -530.91 Thousand |
| Debt repayment | - | - | - | -635 Thousand | -580.47 Thousand | -530.91 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -23.52 Million | 16.07 Million | -36.85 Million | -19.8 Million | 84.47 Million | 1.81 Million |
| Accounts payables | - | - | - | -98.00 | - | - |
| Inventory | 13.33 Million | 47.8 Million | -51.43 Million | -12.59 Million | 54.89 Million | -7.75 Million |
| Other working capital | 38.75 Million | -165.91 Million | 23.89 Million | 29.54 Million | -63.74 Million | -6.67 Million |
| Cash at beginning of period | 11.13 Million | 97.54 Million | 68.09 Million | 12.52 Million | 24.82 Million | 23.23 Million |
| Cash at end of period | 3.21 Million | 11.13 Million | 97.54 Million | 68.09 Million | 12.52 Million | 24.82 Million |
| Capital Expenditure | -3.45 Million | -11.62 Million | -27.93 Million | -22.56 Million | -12.54 Million | -5.87 Million |
| Effect of forex changes on cash | - | - | - | 1000.00 | - | - |
| Net cash flow / Change in cash | -7.92 Million | -86.41 Million | 29.45 Million | 55.56 Million | -12.29 Million | 1.58 Million |
| Free Cash Flow | 65.97 Million | -72.43 Million | 42.27 Million | 130.62 Million | 33.75 Million | 53.75 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.4 Million | -1.64 Million | 1.16 Million | -11.14 Million | 49.2 Million | 3.75 Million |
| Depreciation & Amortization | 16.86 Million | 4.52 Million | 4.52 Million | 4.52 Million | 18.11 Million | 2.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 28.55 Million | - | - | - | -102.03 Million | - |
| Other non-cash items | 90.34 Million | -4.52 Million | -4.52 Million | -4.52 Million | -26.09 Million | -2.2 Million |
| Investing Cash Flow | -77.35 Million | - | - | - | -25.6 Million | - |
| Investments in PPE | -3.45 Million | - | - | - | -11.62 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -73.89 Million | - | - | - | -14 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 28 Thousand | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -23.52 Million | - | - | - | 16.07 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 13.33 Million | - | - | - | 47.8 Million | - |
| Other working capital | 38.75 Million | - | - | - | -165.91 Million | - |
| Cash at beginning of period | 11.13 Million | 1.61 Million | 453 Thousand | 11.13 Million | 97.54 Million | 7.37 Million |
| Cash at end of period | 3.21 Million | -1.64 Million | 1.61 Million | -11.14 Million | 11.13 Million | 11.13 Million |
| Capital Expenditure | -3.45 Million | - | - | - | -11.62 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.92 Million | -3.25 Million | 1.16 Million | -22.28 Million | -86.41 Million | 3.75 Million |
| Free Cash Flow | 65.97 Million | -1.64 Million | 1.16 Million | -11.14 Million | -72.43 Million | 3.75 Million |
9325
VS
LNMG
ATNFW
BIT
PRG